Covidien Receives FDA Clearance To Market Single-Incision Laparoscopic Surgery (SILS(TM)) Kit
May 22nd 2008Drug InformationGastroIntestinal / Gastroentorology
Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced that its Surgical Devices business unit has received FDA 510(k) clearance to market the Covidien SILS? Procedure Kit, indicated for Single-Incision Laparoscopic Surgery and other advanced laparoscopic procedures.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
